文献速递烧伤创面修复

普萘洛尔在成年烧伤患者中的应用:安全性与转归影响

The use of propranolol in adult burn patients: Safety and outcome influence.
PubMed 文献 · Burns · 2021-08-31

一项前瞻性研究将124例重度成年烧伤患者随机分为普萘洛尔组与非普萘洛尔组,普萘洛尔经鼻胃管给药以降低初始心率15-20%。结果显示普萘洛尔安全,可降低能量消耗、限制肝大、加速部分厚度烧伤创面及供皮区愈合,但不影响ICU住院时间、总住院时间、并发症或死亡率。

要点

  • 普萘洛尔平均剂量1.9±0.5 mg/kg/天,范围0.9-3.3 mg/kg/天,不受烧伤面积和吸入性损伤影响。
  • 28天内平均心率降低21.2%,不良事件包括低血压11.9%、心动过缓1.6%、低血糖17.7%。
  • 普萘洛尔组第7天和第14天静息能量消耗显著降低(p<0.05),3周后肝大小无显著变化而非普萘洛尔组显著增大(p<0.05)。

核心结论

  • 对重度成年烧伤患者,普萘洛尔安全且有效,可降低能量消耗、限制肝大、加速部分厚度烧伤创面和供皮区闭合,但不影响ICU住院时间、总住院时间、并发症或死亡率。

研究设计与样本

  • 前瞻性研究,纳入124例重度成年烧伤患者,随机分为普萘洛尔组和非普萘洛尔组。

主要发现

  • 普萘洛尔平均剂量1.9±0.5 mg/kg/天,范围0.9-3.3 mg/kg/天,不受烧伤面积和吸入性损伤影响。
  • 28天内平均心率降低21.2%;不良事件包括低血压11.9%、心动过缓1.6%、低血糖17.7%,总暂停事件8次发生于7例(11.3%)患者。
  • 不同时间点血糖、总蛋白、白蛋白、胆固醇和甘油三酯血清水平两组间无显著差异。
  • 普萘洛尔组第7天和第14天静息能量消耗显著低于非普萘洛尔组(p<0.05)。
  • 3周后普萘洛尔组肝大小较入院无显著变化,而非普萘洛尔组肝大小显著增大(p<0.05);部分厚度烧伤创面和供皮区完全愈合时间普萘洛尔组显著更短(p<0.01);通气时间、ICU住院时间、总住院时间、手术次数、多器官衰竭率和死亡率两组间无差异(p>0.05)。

临床怎么用

  • 作者认为对重度成年烧伤患者,普萘洛尔安全且有效,可降低能量消耗、限制肝大、加速部分厚度烧伤创面和供皮区闭合,但不影响ICU住院时间、总住院时间、并发症或死亡率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study investigated safety and effect of propranolol on adult patients with severe burn. METHODS: A prospective study was conducted on 124 severely adult burn patients who were randomly divided into propranolol and non-propranolol group. Propranolol was given by nasogastric tube to achieve the target of lowering 15-20% of initial heart rate. RESULTS: Average dose of propranolol was 1.9 ± 0.5 mg/kg/day ranging from 0.9 to 3.3 mg/kg/day and was not affected by burn extent and inhalation injury. Mean heart rate reduced by 21.2% during the 28 day period. Recorded adverse events included hypotension (11.9%), bradycardia (1.6%), hypoglycemia (17.7%) and total number of held events was 8 occurring in 7 (11.3%) patients. Serum levels of glucose, total protein, albumin, cholesterol and triglyceride at different times were not significantly different between the two groups. Significantly lower resting energy expenditure on the 7th and 14th day were seen in propranolol group (p < 0.05). After 3 weeks, liver size in the propranolol group did not change significantly from admission, while in the non-propranolol group, liver size increased significantly (p < 0.05). The complete healing time of partial-thickness burns and donor sites were significantly shorter in propranolol group (p < 0.01). Duration of ventilation, length of stay in intensive care unit and in hospital, number of operations, rate of multiple organ failure, and death were not different between the two groups (p > 0.05). CONCLUSION: For severely burned adults, propranolol was safe and effective on reducing energy expenditure, limited hepatomegaly, and accelerated partial burn wound and donor site closure, but does not affect length of stay in ICU, hospitalization, complication ormortality rate.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Lam NN, Khanh PQ, An NH, et al. The use of propranolol in adult burn patients: Safety and outcome influence. Burns. 2021. PMID: 34895792. doi:10.1016/j.burns.2021.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。